These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14755896)

  • 1. Technology evaluation: HSPPC-96, antigenics.
    Minev BR
    Curr Opin Mol Ther; 2003 Dec; 5(6):680-7. PubMed ID: 14755896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future.
    Tosti G; di Pietro A; Ferrucci PF; Testori A
    Expert Rev Vaccines; 2009 Nov; 8(11):1513-26. PubMed ID: 19863242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccine--Antigenics.
    BioDrugs; 2002; 16(1):72-4. PubMed ID: 11909004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous renal cell cancer vaccines using heat shock protein-peptide complexes.
    Aalamian M; Fuchs E; Gupta R; Levey DL
    Urol Oncol; 2006; 24(5):425-33. PubMed ID: 16962495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology evaluation: TroVax, Oxford BioMedica.
    Reinis M
    Curr Opin Mol Ther; 2004 Aug; 6(4):436-42. PubMed ID: 15468602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein-based cancer vaccines.
    Oki Y; Younes A
    Expert Rev Vaccines; 2004 Aug; 3(4):403-11. PubMed ID: 15270645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology evaluation: Onyvax-P, Onyvax.
    Doehn C; Böhmer T; Jocham D
    Curr Opin Mol Ther; 2005 Oct; 7(5):511-9. PubMed ID: 16248287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in heat shock protein-based cancer vaccines.
    Wang HH; Mao CY; Teng LS; Cao J
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous heat shock protein-peptide complexes for vaccination against cancer: from bench to bedside.
    Hoos A; Levey DL; Lewis JJ
    Dev Biol (Basel); 2004; 116():109-15; discussion 133-43. PubMed ID: 15603187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications.
    Hoos A; Levey DL
    Expert Rev Vaccines; 2003 Jun; 2(3):369-79. PubMed ID: 12903802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug evaluation: Therion's rV-PSA-TRICOM + rF-PSA-TRICOM prime-boost prostate cancer vaccine.
    Doehn C; Kausch I; Böhmer T; Sommerauer M; Jocham D
    Curr Opin Mol Ther; 2007 Apr; 9(2):183-9. PubMed ID: 17458173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology evaluation: ALVAC-CEA/B7.1, Aventis Pasteur/Therion.
    Ertl HC
    Curr Opin Mol Ther; 2002 Dec; 4(6):601-5. PubMed ID: 12596363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncophage cancer vaccine shows promise in clinical trials.
    Oncology (Williston Park); 2003 Aug; 17(8):1070, 1094. PubMed ID: 12966675
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell based cancer vaccines: regulatory and commercial development.
    Copier J; Ward S; Dalgleish A
    Vaccine; 2007 Sep; 25 Suppl 2():B35-46. PubMed ID: 17916462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitespen: a preclinical and clinical review.
    Wood CG; Mulders P
    Future Oncol; 2009 Aug; 5(6):763-74. PubMed ID: 19663726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock proteins gp96 as immunogens in cancer patients.
    Parmiani G; De Filippo A; Pilla L; Castelli C; Rivoltini L
    Int J Hyperthermia; 2006 May; 22(3):223-7. PubMed ID: 16754342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology evaluation: SB-485232, GlaxoSmithKline.
    Golab J; Stoklosa T
    Curr Opin Mol Ther; 2005 Feb; 7(1):85-93. PubMed ID: 15732534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.
    di Pietro A; Tosti G; Ferrucci PF; Testori A
    Expert Opin Biol Ther; 2011 Oct; 11(10):1395-407. PubMed ID: 21801084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H; Joniau S; Van Gool SW
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination therapy of melanoma].
    Schuler-Thurner B; Schuler G
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.